SCHEMBL265385

SCHEMBL265385

Cc1ccc(S(=O)(=O)N2CCC(N)C2)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.57
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 1/20 0.56
HTT P42858 2/20 0.56
POLB P06746 1/20 0.56
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
GAA P10253 2/20 0.51
TSHR P16473 1/20 0.51
CYP2C19 P33261 1/20 0.51
LMNA P02545 2/20 0.51
EBP Q15125 1/20 0.51
DHCR7 Q9UBM7 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14086756 0.90 ALDH1A1 (0.64) PKMALDH1A1KDM4EHTTPOLB
SCHEMBL17277538 0.86 PKM (0.59) PKMALDH1A1HTTPOLBMEN1
SCHEMBL1714190 0.83 GAA (0.54) PKMALDH1A1KDM4EPOLBNPC1
SCHEMBL493725 0.83 PKM (0.61) PKMALDH1A1KDM4EHTTPOLB
SCHEMBL4750625 0.82 PKM (0.59) PKMALDH1A1KDM4EHTTPOLB
Hydrochloric Acid SCHEMBL4963034 0.82 GAA (0.53) PKMALDH1A1KDM4EPOLBNPC1
SCHEMBL8185779 0.82 EBP (0.63) PKMALDH1A1KDM4EHTTPOLB
SCHEMBL4750626 0.82 PKM (0.59) PKMALDH1A1KDM4EHTTPOLB
SCHEMBL6882681 0.82 EBP (0.63) PKMALDH1A1KDM4EHTTPOLB
Hydrochloric Acid SCHEMBL4963047 0.82 GAA (0.53) PKMALDH1A1KDM4EPOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574087-B Synthetic method of 3-aminopyrrolidine hydrochloride 南京杰运医药科技有限公司 2022-07-26 CN disclosed
CN-112574087-A Synthetic method of 3-aminopyrrolidine hydrochloride 南京杰运医药科技有限公司 2021-03-30 CN disclosed
US-8431378-B2 Aminotransferase, gene encoding the same, and methods of using them KANEKA CORPORATION (JP) 2013-04-30 US disclosed
US-20120164724-A1 NOVEL AMINOTRANSFERASE, GENE ENCODING THE SAME, AND METHODS OF USING THEM KANEKA CORPORATION (JP) 2012-06-28 US disclosed
US-8133705-B2 Aminotransferase, gene encoding the same, and method of using them KANEKA CORPORATION (JP) 2012-03-13 US disclosed
US-20100285544-A1 Novel aminotransferase, gene encoding the same, and method of using them KANEKA CORPORATION (JP) 2010-11-11 US disclosed
EP-1889907-B1 NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME KANEKA CORP (JP) 2009-09-02 EP disclosed
EP-1889907-A1 NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME Kaneka Corporation (JP) 2008-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100285544-A1 Novel aminotransferase, gene encoding the same, and method of using them BCAT1, AGXT, ALDH7A1 PKM 424/4885ALDH1A1 144/4885KDM4E 2050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.